Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| PI_2023/81 | Other Grant/Funding Number | Department of Health of the Government of Navarra, Spain. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Fundación Instituto de Investigación Sanitaria de Navarra | OTHER |
Not provided
Not provided
Not provided
Not provided
The aim of this study is to evaluate the effectivity of the combined motor imagery and action observation therapies to improve functional parameters such as strenght, range of motion, pain or fear of movements among others in relation to upper limb in breast cancer survivors. The main question it aims to answer is: Will a combined therapy of motor imagery and action observation improve the strenght, rang of motion, pain, limb diameter and fear of movement of the upper limb in breast cancer survivor females? The participants will be part of the IM-OA23 proyect that consist on seeing some diferent videos about upper limb mobility and then they'll have to imagine the movements and to performed themselves. Researches will compare two groups (control group and intervention group) to evaluate the diferences between them.
Purpose: The aim of this study is to evaluate the effectivity of a combined motor imagery and action observation protocol at strength, range of motion, limb diamter, and fear of movement of the upper limb of breast cancer survivors.
Methods: A randomised controlled clinical trial will be conducted. Subjects will be randomly assigned to the two randomly assigned to the two treatment groups: intervention (IM-OA23 programme) and control group (usual care).
This study will have pre and post measurements. The intervention consist on a display of diferent videos of upper limb movements and at daily living activities and in a excercise of imagine and doing this movements. The're will be used diferent tools such as a dynamometer, a goniometer, Visual Analogue Scale (VAS) of pain, or TSK questionnaire.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| IMOA group | Experimental | The intervention group will participate in the IM-OA23 programme; the combination of motor imagery and action observation therapies. |
|
| Control group | No Intervention | The control group will follow the usual care from primary care. There are no care programmes for long term cancer survivors. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Motor imagery combined with action observation | Other | To observe and imaging one action with a video resource. Not virtual reality. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Sthrength | The grip strength of the hand of the affected limb shall be studied, using a dynamometer. | From enrollement to the end of the treatment at 6 weeks and 3 month after |
| Range of Motion | The measurement of the degrees of movement of the shoulder joint by means of a goniometer. The movements of flexion, abduction and internal and external rotation shall be studied using previously established reference points. external rotation, using previously established reference points | From enrollement to the end of the treatment at 6 weeks and 3 month after |
| Pain intensity | Pain intensity will be measured by Visual Analogue Scale (VAS). Participants will have to score their pain on a range from 0 to 10 where 0 means "no pain at all" and 10 "my pain is as bas as it could possibly be". | From enrollement to the end of the treatment at 6 weeks and 3 month after |
| Limb diameter | Limb diameter will be measured by a measuring tape. The measurement is taken at the midpoint between the acromion and the olecranon, the tape being perpendicular to the limb without compressing the area. The midpoint is located with an elbow flexion of 90 degrees and then the measurement is taken with the elbow in extension, the result is expressed in centimetres. | From enrollement to the end of the treatment at 6 weeks and 3 month after |
| Fear of movement | Fear of movement will be measured by the TSK questionnaire | From enrollement to the end of the treatment at 6 weeks and 3 month after |
| Imagery |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Pilar Arnal-Vallés, Candidate PhD | Contact | +34 948166117 | pilararnal3b@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Paula Escalada-Hernández, PhD | Public University of Navarra | Study Director |
| Nelia Soto-Ruiz, PhD | Universidad Pública de Navarra | Study Director |
| Pilar Arnal-Vallés, Candidate PhD |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Public University of Navarre | Not yet recruiting | Pamplona | Navarre | 31008 | Spain |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Imagery will be assessed using the Movement Imagery Questionnaire revised second edition (MIQ-RS)
| From enrollement to the end of the treatment at 6 weeks and 3 month after |
| Hospital of Navarra |
| Principal Investigator |
| Public University of Navarre | Recruiting | Pamplona | Navarre | 31008 | Spain |
| Public University of Navarre | Recruiting | Pamplona | Navarre | 31008 | Spain |
|